Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer - Shaw, AT; Solomon, BJ; Besse, B (J Clin Oncol, 2019)